Showing results (41-50 of 216) with videos related to
Sort By:
Pageof 22
Clinical and Translational Gastroenterology|August 7, 2025
Predictive Validity of the TIGER Score for Daily-Life Disease Burden, Complications, and Medication Use in Inflammatory Bowel Disease After 12 MonthsEran Zittan, Matthew Levy, Shiraz Vered, et al.Journal of Crohn'S & Colitis|October 21, 2020
COVID-19 Pandemic: Which IBD Patients Need to Be Scoped-Who Gets Scoped Now, Who Can Wait, and how to Resume to NormalSiew C Ng, Joyce Wing Yan Mak, Lara Hitz, et al.Clinical and Translational Gastroenterology|May 23, 2019
Mucosa-Associated Microbiota in Ileoanal Pouches May Contribute to Clinical Symptoms, Particularly Stool Frequency, Independent of Endoscopic Disease ActivityWilliams Turpin, Orlaith Kelly, Krzysztof Borowski, et al.Journal of Crohn'S & Colitis|April 25, 2015
Vaccination in inflammatory bowel disease patients: attitudes, knowledge, and uptakeGurtej Malhi, Amir Rumman, Reka Thanabalan, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 7, 2009
A systematic prospective comparison of noninvasive disease activity indices in ulcerative colitisDan Turner, Cynthia H Seow, Gordon R Greenberg, et al.European Journal of Gastroenterology & Hepatology|August 17, 2021
Higher adalimumab maintenance regimen is more effective than standard dose in anti-TNF experienced Crohn's disease patientsTomer Greener, Karen Boland, Raquel Milgrom, et al.Inflammatory Bowel Diseases|July 8, 2025
Construct Validity of the Toronto IBD Global Endoscopic Reporting Score Compared to Inflammatory Biomarkers After 12-Month Follow-UpEran Zittan, Matthew Levy, Shiraz Vered, et al.The American Journal of Gastroenterology|October 13, 2006
Psychobiological subtypes of ulcerative colitis: pANCA status moderates the relationship between disease activity and psychological distressRobert G Maunder, Gordon R Greenberg, Jonathan J Hunter, et al.Canadian Journal of Gastroenterology & Hepatology|February 28, 2017
Public versus Private Drug Insurance and Outcomes of Patients Requiring Biologic Therapies for Inflammatory Bowel DiseaseAmir Rumman, Roberto Candia, Justina J Sam, et al.International Journal of Surgery (London, England)|March 31, 2019
Preoperative exposure to anti-tumor necrosis factor therapy in ulcerative colitis patients undergoing ileal pouch-anal anastomosis (IPAA) is not associated with histological fibrosis: A case control studyEran Zittan, Jennifer Muir, Raquel Milgrom, et al.Pageof 22